Skip to content

Impact of Doula Support on Childbirth Outcomes for Women Undergoing a Vaginal Birth After Cesarean (VBAC)

Impact of Doula Support on Intrapartum Outcomes for Women Undergoing a Vaginal Birth After Cesarean (VBAC)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01216098
Enrollment
82
Registered
2010-10-07
Start date
2010-10-31
Completion date
2015-02-28
Last updated
2015-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean

Keywords

Intrapartum, Clinical trial, Perinatal, Doula, VBAC, Perinatal Outcomes

Brief summary

The purpose of this study is to evaluate the impact of doula support on childbirth outcomes of women who are eligible for and attempting to have a Vaginal Birth After Cesarean (VBAC). Doulas are paraprofessionals who provide women with continuous physical and emotional support throughout the course of labour. They also conduct home visits in the prenatal and postpartum periods in order to provide women with information on childbirth-related topics and breastfeeding support. They do not perform clinical tasks. Their value lies in the psycho-social care that they provide. It is hypothesized that women who receive doula support alongside standard care will have a lower rate of epidural analgesia use and greater cervical dilation at time of epidural administration, as compared to those who receive standard care alone.

Detailed description

A two-armed randomized controlled trial will be conducted at BC Women's Hospital. The experimental group will receive both standard clinical care and doula support. The control group will receive standard clinical care without doula support. The main outcomes being looked at are use of epidural analgesia and cervical dilation at time of epidural administration. These outcomes have been chosen because of the association between the use of epidural analgesia and both a prolonged length of labour and the need for assisted deliveries (i.e. forceps assisted deliveries, vacuum assisted deliveries, and cesarean births). If it is found that providing doula support for women who are eligible for and attempting to have a VBAC reduces or delays the use of epidural analgesia, then it could be hypothesized that doula support for this population may also shorten the length of labour and reduce the need for assisted deliveries, thereby justifying ongoing research in this area.

Interventions

BEHAVIORALDoula support

A doula is a paraprofessional who provides continuous emotional and physical support to women and their families during the intrapartum period.

Sponsors

Provincial Health Services Authority (PHSA)
CollaboratorUNKNOWN
University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Women who have had at least one prior cesarean birth, are eligible for VBAC, and plan to attempt a VBAC after counseling at the Best Birth Clinic. * Singleton gestation. * Cephalic presentation. * Term gestation (37-42 weeks at time of delivery).

Exclusion criteria

* Women who have a pre-existing medical condition that would be an indication for an elective cesarean birth. * Women who plan to privately hire a doula regardless of placement in either arm of the trial.

Design outcomes

Primary

MeasureTime frameDescription
Use of epidural analgesia and cervical dilation at time of epidural administration.The main outcomes being looked at are use of epidural analgesia and cervical dilation at time of epidural administration. This information will be recorded in the patient charts during the intrapartum period and collected from these charts at a later date by a research assistant.

Secondary

MeasureTime frameDescription
Cervical dilation at time of epidural administrationThe following secondary outcomes will be measured: * Use of nitrous oxide analgesia during labour. * Use of narcotic analgesia during labour (type and amount). * Number of visits to the assessment room before admission. * Mode of delivery (cesarean section, spontaneous vaginal, or forceps/vacuum). * Indication(s) for repeat cesarean (if applicable). * Length of time between admission and the start of active pushing. * Length of time between the start of active pushing and delivery. * Length of time between delivery and discharge.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026